Alphabet »

Lyell Immunopharma shares owned by Alphabet

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Alphabet from 13F filings

Historical chart of Alphabet investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Alphabet consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Alphabet

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.8M 293k 16.24
2025-06-30 $2.6M 293k 8.84

More positions owned by Alphabet

Ast Spacemobile Com Cl A (ASTS)
Planet Labs Pbc Com Cl A (PL)
Arm Holdings Sponsored Ads (ARM)
Mestera (MTSR)
Revolution Medicines (RVMD)
Freshworks Class A Com (FRSH)
Tempus Ai Cl A (TEM)
Gitlab Class A Com (GTLB)
Uipath Cl A (PATH)
Prime Medicine (PRME)
Dex (DXCM)
Maze Therapeatics (MAZE)
Bridgebio Oncology Therapeut Com New
Figma Class A Com Stk (FIG)
Monte Rosa Therapeutics (GLUE)

View all positions for Alphabet

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Foresite Capital Management IV
Vanguard Group
Orland Properties
Almitas Capital
Foresite Capital Management V
venBio Partners
Citadel Advisors
Alphabet
BlackRock
Sc China Holding
Geode Capital Management
Millennium Management
Rbf Capital

View all funds holding Lyell Immunopharma